HALO - Halozyme Therapeutics Inc. (HALO) CEO Helen Torley on Q4 2020 Results - Earnings Call Transcript
Halozyme Therapeutics, Inc. (HALO) Q4 2020 Earnings Conference Call February 23, 2021 04:30 PM ET Company Participants Al Kildani - Vice President of Investor Relations & Corporate Communications Helen Torley - President & Chief Executive Officer Elaine Sun - Chief Financial Officer Conference Call Participants Charles Duncan - Cantor Fitzgerald Do Kim - BMO Jim Birchenough - Wells Fargo Anita Dushyanth - Berenberg Capital Benjamin Paluch - Citi Ben Shim - Canaccord Genuity Presentation Operator Ladies and gentlemen, thank you for standing by and welcome to the Halozyme Fourth Quarter 2020 Financial Results Conference Call. At this time all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to turn the conference over to Al Kildani, Vice President of Investor Relations and Corporate Communications for Halozyme Therapeutics. Mr. Kildani, please begin. Al Kildani Thank you. Good afternoon
For further details see:
Halozyme Therapeutics, Inc. (HALO) CEO Helen Torley on Q4 2020 Results - Earnings Call Transcript